Kirkwood JM - Search Results

1

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Kalinski P, Edington H, Zeh HJ, Okada H, Butterfield LH, Kirkwood JM, Bartlett DL. Kalinski P, et al. Among authors: kirkwood jm. Immunol Res. 2011 Aug;50(2-3):235-47. doi: 10.1007/s12026-011-8224-z. Immunol Res. 2011. PMID: 21717071 Free PMC article.

2

Molecular analysis of melanoma precursor lesions.

Wang Y, Rao U, Mascari R, Richards TJ, Panson AJ, Edington HD, Shipe-Spotloe JM, Donnelly SS, Kirkwood JM, Becker D. Wang Y, et al. Among authors: kirkwood jm. Cell Growth Differ. 1996 Dec;7(12):1733-40. Cell Growth Differ. 1996. PMID: 8959342

3

Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.

Kirkwood JM, Farkas DL, Chakraborty A, Dyer KF, Tweardy DJ, Abernethy JL, Edington HD, Donnelly SS, Becker D. Kirkwood JM, et al. Mol Med. 1999 Jan;5(1):11-20. Mol Med. 1999. PMID: 10072444 Free PMC article.

4

Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.

Yang P, Farkas DL, Kirkwood JM, Abernethy JL, Edington HD, Becker D. Yang P, et al. Among authors: kirkwood jm. Mol Med. 1999 Dec;5(12):785-94. Mol Med. 1999. PMID: 10666478 Free PMC article.

5

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Lotze MT, Shurin M, Esche C, Tahara H, Storkus W, Kirkwood JM, Whiteside TL, Elder EM, Okada H, Robbins P. Lotze MT, et al. Among authors: kirkwood jm. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S61-6. Cancer J Sci Am. 2000. PMID: 10685662 Review.

6

Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading.

Ranieri E, Kierstead LS, Zarour H, Kirkwood JM, Lotze MT, Whiteside T, Storkus WJ. Ranieri E, et al. Among authors: kirkwood jm. Immunol Invest. 2000 May;29(2):121-5. doi: 10.3109/08820130009062294. Immunol Invest. 2000. PMID: 10854179 No abstract available.

7

Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.

Kirkwood JM, Mascari RA, Edington HD, Rabkin MS, Day RS, Whiteside TL, Vlock DR, Shipe-Spotloe JM. Kirkwood JM, et al. Cancer. 2000 Jun 15;88(12):2693-702. Cancer. 2000. PMID: 10870051 Clinical Trial.

8

Biologic therapy.

Edington H, Agarwala S, Kirkwood JM. Edington H, et al. Among authors: kirkwood jm. Clin Plast Surg. 2000 Oct;27(4):643-65. Clin Plast Surg. 2000. PMID: 11039895 Review.

9

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

Zarour HM, Maillere B, Brusic V, Coval K, Williams E, Pouvelle-Moratille S, Castelli F, Land S, Bennouna J, Logan T, Kirkwood JM. Zarour HM, et al. Among authors: kirkwood jm. Cancer Res. 2002 Jan 1;62(1):213-8. Cancer Res. 2002. PMID: 11782380

10

Melanoma vaccines: early progress and future promises.

Zarour HM, Kirkwood JM. Zarour HM, et al. Among authors: kirkwood jm. Semin Cutan Med Surg. 2003 Mar;22(1):68-75. doi: 10.1053/sder.2003.50006. Semin Cutan Med Surg. 2003. PMID: 12773015 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters